05B4 Parvizi, Javad - Thomas Jefferson University - Thomas Jefferson University

Javad Parvizi, MD, FRCS

Contact Dr. Parvizi

925 Chestnut Street
5th Floor
Philadelphia, PA 19107

(800) 321-9999

Most Recent Peer-reviewed Publications

  1. Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin
  2. Prevention of Periprosthetic Joint Infection
  3. Intraoperative Purulence Is Not Reliable for Diagnosing Periprosthetic Joint Infection
  4. Premature Therapeutic Antimicrobial Treatments Can Compromise the Diagnosis of Late Periprosthetic Joint Infection
  5. CORR Insights®: Increased Risk of Periprosthetic Femur Fractures Associated With a Unique Cementless Stem Design
  6. Is Neuraxial Anesthesia Safe in Patients Undergoing Surgery for Treatment of Periprosthetic Joint Infection?
  7. Prevention of periprosthetic joint infection: Pre-, intra-, and postoperative strategies | Prevencija periproteti─Źkih infekcija: Prije, -intra i poslijeoperacijska strategija
  8. Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty
  9. Does the Nature of Chondrolabral Injury Affect the Results of Open Surgery for Femoroacetabular Impingement?
  10. Periprosthetic shoulder infection in the United States: Incidence and economic burden
  11. Biological response to prosthetic debris
  12. The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip
  13. Total joint arthroplasty in cancer patients
  14. Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment
  15. Is tantalum protective against infection in revision total hip arthroplasty?
  16. Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: Warfarin versus aspirin
  17. The impact of total joint arthroplasty on sexual function in young, active patients
  18. Treating periprosthetic joint infections as biofilms: Key diagnosis and management strategies
  19. Introduction
  20. In-Hospital Morbidity and Mortality Following Total Joint Arthroplasty in Patients with Hemoglobinopathies